Dr. Heather E. Stefanski, MD, PhD, is a leading authority in pediatric hematology, stem cell transplantation, and cell therapy innovation. As Executive Vice President of CIBMTR and Clinical Services at the National Marrow Donor Program (NMDP), she drives national and global initiatives focused on donor safety, transplant access, and cellular therapy advancement. With over 65 peer-reviewed publications and multiple patents, Dr. Stefanski blends clinical excellence with groundbreaking research to improve outcomes for patients worldwide. She serves in key leadership roles across the WMDA, ASH, and ASTCT, and is recognized for her visionary contributions to donor health and translational medicine.

After more than three decades dedicated to advancing veterinary oncology, translational research, and compassionate clinical care, I’m honored to share this comprehensive view of my professional journey. From pioneering cancer immunotherapies to mentoring the next generation of oncologists, my mission has always centered on improving lives—both animal and human—through innovation and collaboration. Here is my biography.

After nearly two decades at the intersection of science, strategy, and innovation, I've had the privilege of building and leading teams that transform how healthcare organizations use data and technology to deliver more equitable, efficient, and impactful care. I'm proud to share my professional biography that captures this journey.

I'm honored to share my professional journey and the values that guide my work in healthcare, policy, and leadership. Over the past 20 years, I’ve had the privilege to serve communities through roles in clinical research, operations strategy, and public health advocacy. Here is my biography.

I’m honored to share a snapshot of my professional journey, which spans over 30 years in nursing, education, and clinical leadership. From working with patients across the lifespan to mentoring the next generation of nurse practitioners and leading graduate programs, my mission has always been grounded in service, growth, and excellence. Here is my biography.

I'm a global medical affairs leader with over two decades of experience spanning clinical research, regulatory strategy, and pharmaceutical innovation across Latin America and the United States. Throughout my career, I've had the privilege of guiding high-performing teams, launching impactful therapies, and aligning regional execution with global vision—most recently as Head of Medical Affairs for Emerging Therapy Areas at Novo Nordisk. Passionate about advancing patient outcomes and fostering collaborative leadership, I bring a strategic, people-centered approach to everything I do in the healthcare space.

I’m passionate about transforming healthcare through ethical data innovation, strategic leadership, and empowering the next generation of women in tech and science. With over 20 years of experience in healthcare analytics, AI, and data governance, I’ve led global teams, shaped operational strategy, and served on advisory boards and nonprofit foundations. Whether through mentoring, publishing, or speaking on global stages, I’m committed to advancing equitable, data-driven solutions that improve lives and elevate leadership across industries.

I’m a seasoned clinical research professional with over two decades of experience supporting and leading clinical trials across all phases and therapeutic areas. My journey has taken me through top pharmaceutical organizations like Bristol Myers Squibb, GSK, Karuna Therapeutics, and AstraZeneca, where I’ve specialized in clinical operations, regulatory compliance, and team development. I’m passionate about building efficient systems, mentoring others, and contributing to work that ultimately improves patient lives.

After nearly three decades in healthcare and higher education, I’ve had the privilege of serving in roles that span clinical care, academic leadership, and strategic innovation. I’m passionate about building systems that elevate nursing education, drive student success, and create meaningful impact. Here is my biography.

Dr. Kashinath Yadalam is a seasoned psychiatrist and clinical research leader with over 40 years of experience advancing treatments for psychiatric and neurological disorders. As Owner and Medical Director of Lake Charles Clinical Trials, he has built a respected institution known for its high standards in ethical, safe, and innovative clinical research. A Distinguished Life Fellow of the American Psychiatric Association and a Certified Physician Investigator, Dr. Yadalam has collaborated with pharmaceutical companies, academic institutions, and regulatory bodies to design and oversee groundbreaking trials in psychopharmacology. His career reflects a lifelong commitment to improving mental health care through scientific rigor, compassionate practice, and academic excellence.

Dr. Violanda Grigorescu is a globally recognized leader in public health, clinical science, and biomedical informatics with over 40 years of experience spanning federal, state, and international roles. She has held senior positions at the NIH, CDC, and Michigan Department of Community Health, where she led transformative initiatives in maternal and child health, health data infrastructure, and epidemiologic research. Known for building collaborative ecosystems across agencies and disciplines, Dr. Grigorescu has pioneered groundbreaking programs integrating AI, FHIR standards, and advanced analytics to improve health outcomes and policy. Her career reflects a rare blend of clinical expertise, strategic leadership, and a deep commitment to equity and innovation in healthcare systems.

Christopher Roche is a seasoned medical device executive with over 23 years of experience driving innovation in orthopedic technology and global commercialization. As Senior Vice President of Extremities at Exactech, he has led the division’s transformation into a $200 million business while contributing over 140 peer-reviewed publications and securing 38 patents. A member of the AIMBE College of Fellows and a recognized thought leader, Christopher blends deep biomedical engineering expertise with strategic vision and a passion for mentoring and global collaboration.

Dr. Gilles Besin is a visionary scientific executive whose career spans over 20 years at the forefront of RNA therapeutics and immunology. As Chief Scientific Officer at Orbital Therapeutics, he is redefining the landscape of next-generation RNA medicine through groundbreaking work in mRNA and circular RNA platforms. From leading vaccine development programs to spearheading major biotech acquisitions, Dr. Besin blends deep scientific expertise with strategic insight, positioning him as a driving force in translating cutting-edge research into real-world therapeutic solutions.

Dr. Hassan Razvi is a globally respected healthcare innovator and urological surgeon with over three decades of experience advancing medical research, device development, and clinical excellence. Known for his leadership in early-stage product innovation through to clinical trials, he has contributed extensively to the global medical community through board service, international collaboration, and impactful communication. Dr. Razvi's ability to translate complex clinical insights into strategic direction makes him a valuable advisor to companies aiming to grow and innovate in the healthcare, pharmaceutical, and medical device industries.

I'm excited to share my professional biography, capturing the journey I've taken across HEOR, pharmaceutical innovation, real-world evidence, and health policy. With over 20 years of experience in building value through data, strategic insight, and collaborative leadership, I'm proud to continue this work alongside inspiring teams and partners.

Dr. Michael E. Kuligowski, MD, PhD, MBA, is a globally recognized physician-executive with over four decades of leadership in dermatology, clinical development, and pharmaceutical strategy. With a distinguished career spanning Europe and the United States, he has led the development and approval of numerous dermatologic therapies, including Opzelura® for atopic dermatitis and vitiligo. Known for his scientific rigor, strategic foresight, and collaborative leadership, Dr. Kuligowski continues to influence the future of dermatologic innovation through executive roles, advisory board appointments, and pro-bono consulting in the life sciences sector.